Skip to main content

Table 1 Direct cost of treatment for hyperkinetic disorder, epilepsy, and asthma in Germany for the age group < 15 years, shown by diagnosis and type of treatment.

From: Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years

Diagnosis/Treatment

Total cost of treatment for 2002 in millions

Total cost of treatment for 2004 in millions

Total cost of treatment for 2006 in millions

Hyperkinetic disorder

€ 158 (100%)

€ 205 (100%)

€ 287 (100%)

   Inpatient treatment

€ 73 (46.2%)

€ 93 (45.4%)

€ 112 (39.0%)

   Outpatient treatment

€ 12 (7.6%)

€ 14 (6.8%)

€ 21 (7.3%)

   Medication (outpatients)

€ 12 (7.6%)

€ 28 (13.7%)

€ 81 (28.2%)

   Other treatment costs

€ 61 (38.6%)

€ 70 (34.2%)

€ 73 (25.4%)

Epilepsy

€ 157 (100%)

€ 155 (100%)

€ 155 (100%)

   Inpatient treatment

€ 74 (47.1%)

€ 73 (47.1%)

€ 73 (47.1%)

   Outpatient treatment

€ 9 (5.7%)

€ 8 (5.2%)

€ 9 (5.8%)

   Medication (outpatients)

€ 22 (14.0%)

€ 24 (15.5%)

€ 24 (15.5%)

   Other treatment costs

€ 52 (33.1%)

€ 50 (32.3%)

€ 49 (31.6%)

Asthma

€ 266 (100%)

€ 257 (100%)

€ 272 (100%)

   Inpatient treatment

€ 92 (34.6%)

€ 83 (32.3%)

€ 82 (30.1%)

   Outpatient treatment

€ 27 (10.2%)

€ 32 (12.5%)

€ 40 (14.7%)

   Medication (outpatients)

€ 103 (38.7%)

€ 98 (38.1%)

€ 105 (38.6%)

   Other treatment costs

€ 44 (16.5%)

€ 44 (17.1%)

€ 45 (16.5%)